Citadel Advisors - IMMUNOCELLULAR THERAPEUTICS ownership

Back to all holdings Add to watchlist

IMMUNOCELLULAR THERAPEUTICS's ticker is and the CUSIP is 452536955. A total of 3 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Citadel Advisors ownership history of IMMUNOCELLULAR THERAPEUTICS
ValueSharesWeighting
Q2 2014$1,000
-88.9%
1,000
-86.3%
0.00%–
Q1 2014$9,000
-71.0%
7,300
-78.1%
0.00%–
Q4 2013$31,000
-11.4%
33,300
+146.7%
0.00%–
Q3 2013$35,000–13,500–0.00%–
 Download
Other shareholders
IMMUNOCELLULAR THERAPEUTICS shareholders Q1 2014
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,405$293,0000.02%
GROUP ONE TRADING, L.P. 62,800$77,0000.00%
Citadel Advisors 7,300$9,0000.00%
View complete list of IMMUNOCELLULAR THERAPEUTICS shareholders